MedTrace Logo

Primary Reperfusion Secondary Stenting Trial

NCT01542385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 307

Last updated 2020-08-05

No results posted yet for this study

Summary

The purpose of this research project is to improve how we treat heart attacks. The study will assess whether it might not be better to wait a few hours before implanting the coronary stent into the coronary artery rather than implanting it immediately, in order to allow the drugs to completely dissolve the clot. This might help to reduce the risks of the clot migrating and damaging the heart. By delaying coronary stent implantation, we hope to be able to reduce the size of the infarction and reduce the risk of suffering from heart failure following a heart attack.

Conditions

  • ST-elevation Myocardial Infarction

Interventions

PROCEDURE

Stent

Percutaneous coronary intervention: reperfusion with a thrombectomy catheter or a small balloon angioplasty catheter, followed by coronary stenting

Sponsors & Collaborators

  • Montreal Heart Institute

    lead OTHER

Principal Investigators

  • Marc E Jolicoeur, MD MSc MHS · Montreal Heart Institute, Université de Montréal

  • Nandini Dendukuri, PhD · Centre for Outcomes Research, McGill University Health Centre - Research Institute

  • Loic Belle, MD · Hospital of Annecy, Centre Hospitalier Annecy Genevois, Annecy, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-05-31
Completion
2019-08-31

Countries

  • Canada
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542385 on ClinicalTrials.gov